Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1Experimental: Seladelpar / MBX-8025 200 mg1件: Seladelpar1件: D11256 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93
2Experimental: Seladelpar / MBX-8025 50 mg1件: Seladelpar1件: D11256 1件: PPARG 💬11件: AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬1件: 93
3MBX-8025----3件: 79, 93, 94
4MBX-8025 10 mg Capsule----1件: 93
5MBX-8025 2 mg Capsule----1件: 93
6MBX-8025 5 mg Capsule----1件: 93
7MBX-8025 50 mg (Dose Escalation Period 1)----1件: 79
8MBX-8025 50 mg or 100 mg (Dose Escalation Period 2)----1件: 79
9MBX-8025 50 mg, 100 mg or 200 mg (Dose Escalation Period 3)----1件: 79
10MBX-8025, DSIC----1件: 93
11MBX-8025, Formulation 2----1件: 93